MAPT and Alzheimer disease: However, an in vivo study involving oral copper administration to AD transgenic mice has contrastingly revealed a marked increase in CDK5/p25 complex activity but no significant activation of the GSK-3β kinase, implying that the GSK-3β kinase may not necessarily be involved in tau hyperphosphorylation [46].